Cipla trades in green on the BSE

Cipla is currently trading at Rs. 394.95, up by 4.25 points or 1.09% from its previous closing of Rs. 390.70 on the BSE. The scrip opened at Rs. 392.00 and has touched a high and low of Rs. 396.85 and Rs. 391.05 respectively. So far 140740 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 450.00 on 16-Sep-2013 and a 52 week low of Rs. 364.05 on 03-Jun-2013. Last one week high and low of the scrip stood at Rs. 396.25 and Rs. 381.55 respectively. The current market cap of the company is Rs. 31711.38 crore. The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 34.75% and 27.35% respectively. Cipla’s wholly owned subsidiary -- Cipla (EU), UK -- has signed a definitive agreement to invest $1.5 million in Chase Pharmaceuticals Corporation Inc, US to acquire 14.6% stake in Chase on a fully diluted basis. Cipla will make an additional $4.5 million investment in Chase upon achievement of certain milestones. Chase is an early stage drug development company developing novel approaches to improve treatments for Alzheimer’s disease. Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.